ISLAND PHARMACEUTICALS LTD
Clinical trial NCT05681624 updates: 1. enrollment: 2124 → 2252 participants 2. primary purpose: TREATMENT → PREVENTION
Clinical trial NCT05681624 updates: 1. enrollment: 2124 → 2252 participants 2. primary purpose: TREATMENT → PREVENTION
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical